T1	Participants 115 123	melanoma
T2	Participants 134 315	Nearly 2000 patients with stage IIB and III melanoma have participated in four multicenter, randomized trials, conducted by the Eastern Cooperative Oncology Group and the Intergroup
T3	Participants 819 842	713 patients randomized
T4	Participants 492 530	treatment effects based on pooled data
